Prostate Specific Antigen
Customize your policy alerts
Sign up for Providence Health Plan Policy 320 alerts
Get alerted when Policy 320 changes without checking for updates manually.
Monitor payer policy activity
This Medicare-only policy governs coverage and billing of total prostate-specific antigen (PSA) testing. Coverage follows CMS NCD 190.31 and applicable medical-necessity and diagnosis-code requirements; screening PSA testing is outside this policy.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.